Community-level chlamydial serology for assessing trachoma elimination in trachoma-endemic Niger.

Community-level chlamydial serology for assessing trachoma elimination in trachoma-endemic Niger.

BACKGROUND:Program decision-making for trachoma elimination currently relies on conjunctival clinical signs. Antibody tests may provide additional information on the epidemiology of trachoma, particularly in regions where it is disappearing or elimination targets have been met. METHODS:A cluster-ran...

Full description

Bibliographic Details
Main Authors:	Jessica S Kim, Catherine E Oldenburg, Gretchen Cooley, Abdou Amza, Boubacar Kadri, Baido Nassirou, Sun Yu Cotter, Nicole E Stoller, Sheila K West, Robin L Bailey, Jeremy D Keenan, Bruce D Gaynor, Travis C Porco, Thomas M Lietman, Diana L Martin
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2019-01-01
Series:	PLoS Neglected Tropical Diseases
Online Access:	http://europepmc.org/articles/PMC6366708?pdf=render

Similar Items

The distribution of the prevalence of ocular chlamydial infection in communities where trachoma is disappearing
by: Thomas M. Lietman, et al.
Published: (2015-06-01)

Short-term forecasting of the prevalence of clinical trachoma: utility of including delayed recovery and tests for infection
by: Fengchen Liu, et al.
Published: (2015-10-01)

The easiest children to reach are most likely to be infected with ocular Chlamydia trachomatis in trachoma endemic areas of Niger.
by: Abdou Amza, et al.
Published: (2013-01-01)

Short-term Forecasting of the Prevalence of Trachoma: Expert Opinion, Statistical Regression, versus Transmission Models.
by: Fengchen Liu, et al.
Published: (2015-08-01)

Correction: Short-term Forecasting of the Prevalence of Trachoma: Expert Opinion, Statistical Regression, versus Transmission Models.
by: Fengchen Liu, et al.
Published: (2015-09-01)

Azithromycin Reduction to Reach Elimination of Trachoma (ARRET): study protocol for a cluster randomized trial of stopping mass azithromycin distribution for trachoma
by: Abdou Amza, et al.
Published: (2021-01-01)

Monitoring transmission intensity of trachoma with serology
by: Christine Tedijanto, et al.
Published: (2023-06-01)

Sensitivity and specificity of computer vision classification of eyelid photographs for programmatic trachoma assessment.
by: Matthew C Kim, et al.
Published: (2019-01-01)

Identifying a sufficient core group for trachoma transmission.
by: Thomas M Lietman, et al.
Published: (2018-10-01)

Does mass azithromycin distribution impact child growth and nutrition in Niger? A cluster-randomized trial.
by: Abdou Amza, et al.
Published: (2014-09-01)

The distribution of ocular Chlamydia prevalence across Tanzanian communities where trachoma is declining.
by: Salman A Rahman, et al.
Published: (2015-03-01)

Correction: The Distribution of Ocular Chlamydia Prevalence across Tanzanian Communities Where Trachoma Is Declining.
by: Salman A Rahman, et al.
Published: (2015-05-01)

Forecasting trachoma control and identifying transmission-hotspots
by: Blumberg, S, et al.
Published: (2021)

Stopping azithromycin mass drug administration for trachoma: A systematic review.
by: Hamidah Mahmud, et al.
Published: (2021-07-01)

Models of trachoma transmission and their policy implications: From control to elimination
by: Lietman, T, et al.
Published: (2018)

The utility of serology for elimination surveillance of trachoma
by: Amy Pinsent, et al.
Published: (2018-12-01)

Mass azithromycin distribution for hyperendemic trachoma following a cluster-randomized trial: A continuation study of randomly reassigned subclusters (TANA II).
by: Jeremy D Keenan, et al.
Published: (2018-08-01)

Linear growth in preschool children treated with mass azithromycin distributions for trachoma: A cluster-randomized trial.
by: Jeremy D Keenan, et al.
Published: (2019-06-01)

Eliminating Trachoma in Areas with Limited Disease
by: Bruce D. Gaynor, et al.
Published: (2003-05-01)

Trachoma prevalence after discontinuation of mass azithromycin distribution
by: Godwin, W, et al.
Published: (2020)

Biannual versus annual mass azithromycin distribution and malaria seroepidemiology among preschool children in Niger: a sub-study of a cluster randomized trial
by: Catherine E. Oldenburg, et al.
Published: (2019-12-01)

The SAFE strategy for the elimination of trachoma by 2020: will it work?
by: Robin Bailey, et al.

The SAFE strategy for the elimination of trachoma by 2020: will it work?
by: Bailey Robin, et al.
Published: (2001-01-01)

Elements of a dirty face as individual risk factors for trachoma, from a cluster-randomized trial in Niger
by: J. Kim, et al.
Published: (2015-03-01)

Probabilistic forecasts of trachoma transmission at the district level: A statistical model comparison
by: Amy Pinsent, et al.
Published: (2017-03-01)

Importance of coverage and endemicity on the return of infectious trachoma after a single mass antibiotic distribution.
by: Takele Lakew, et al.
Published: (2009-08-01)

Assessment of transmission in trachoma programs over time suggests no short-term loss of immunity.
by: Fengchen Liu, et al.
Published: (2013-01-01)

Reduction and return of infectious trachoma in severely affected communities in Ethiopia.
by: Takele Lakew, et al.
Published: (2009-01-01)

When can antibiotic treatments for trachoma be discontinued? Graduating communities in three African countries.
by: Kathryn J Ray, et al.
Published: (2009-06-01)

Immunoglobulins in trachoma
by: Nema H, et al.
Published: (1977-01-01)

Betamethasone and trachoma
by: Jain N, et al.
Published: (1979-01-01)

Berberine in trachoma
by: Mohan Madan, et al.
Published: (1982-01-01)

Correction: Assessment of Transmission in Trachoma Programs over Time Suggests No Short-Term Loss of Immunity
by: Fengchen Liu, et al.
Published: (2013-07-01)

Correction: Assessment of Transmission in Trachoma Programs over Time Suggests No Short-Term Loss of Immunity.
by: Fengchen Liu, et al.
Published: (2013-07-01)

CT694 and pgp3 as serological tools for monitoring trachoma programs.
by: E Brook Goodhew, et al.
Published: (2012-01-01)

Serology for trachoma surveillance after cessation of mass drug administration.
by: Diana L Martin, et al.
Published: (2015-02-01)

The efficacy of oral azithromycin in clearing ocular chlamydia: Mathematical modeling from a community-randomized trachoma trial
by: Fengchen Liu, et al.
Published: (2014-03-01)

Implications of the COVID-19 pandemic in eliminating trachoma as a public health problem
by: Blumberg, S, et al.
Published: (2021)

Trachoma: the beginning of the end?
by: Danny Haddad
Published: (2012-01-01)

Clinical picture of trachoma
by: Dhanda R
Published: (1968-01-01)